68-1
71/98

10) Lojanapiwat B, Lee JY, Gang Z, Kim CS, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Lee SH, Türkeri L, Murphy DG, Moretti K, Cooperberg M, Carlile R, Hinotsu S, Hirao Y, Kitamura T, Horie S, Onozawa M, Kitagawa Y, Namiki M, Fukagai T, Miyazaki J, Akaza H: Report of the third Asian Prostate Cancer study meeting. Prostate Int, 2019; 7: 60-67. 11) Murasawa H, Sugiyama T, Matsuoka Y, Okabe T, Hino A, Tanaka N, Sugimoto M, Oyama M, Fujimoto K, Horie S, Noto S, Shimozuma K: Health utility and health- related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P. Qual. Life Res, 2019; 28: 2383-2391.* 12) Ohtaka A, Aoki H, Nagata M, Kanayama M, Shimizu F, Ide H, Tsujimura A, Horie S: Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy. Prostate Int, 2019; 7: 9-14. 13) Fink J, Schoenfeld BJ, Hackney AC, Matsu‑moto M, Maekawa T, Nakazato K, Horie S: Anabolic-androgenic steroids: procurement and administration practices of doping athletes. Phys. Sportsmed, 2019; 47: 10-14.* 14) Aoki Y, Tsujimura A, Nagashima Y, Hira‑matsu I, Uesaka Y, Nozaki T, Ogishima T, Shirai M, Shoyama Y, Tanaka H, Horie S: Effect of Lepidium meyenii on in vitro fertil‑ization via improvement in acrosome reac‑tion and motility of mouse and human sperm, Reprod Med Biol, 2019; 18: 57-64.* 15) Hiramatsu I, Tsujimura A, Soejima M, Yoshi‑yama A, Nagashima Y, Ishikawa K, Uesaka Y, Nozaki T, Ogishima T, Shirai M, Mitsuhashi I, Sugimura S, Mizuno T, Noto K, Shigeta Y, Takasu J, Honda S, Iwata S, Horie S: Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia. Int J Urol, 2019; 27: 53-57. 16) Tsujimura A, Hiramatsu I, Nagashima Y, Ishikawa K, Uesaka Y, Nozaki T, Ogishima T, Shirai M, Terai K, Kobayashi K, Horie S: Erectile dysfunction is predictive symptom for poor semen in newlywed men in Japan. Sexual Med, 2019. pii: S2050-1161(19)30196-5. doi: 10.1016/j.esxm.2019.09.005. 17) Tanaka H, Miyagawa Y, Tsujimura A, Wada M: Genetic polymorphisms within the intron‑less ACTL7A and ACTL7B genes encoding spermatogenesis-specific actin-like proteins in Japanese males. Int. J. Fertil. Steril, 2019; 13: 245-249. 18) Yumura Y, Tsujimura A, Okada H, Ota K, Kitazawa M, Suzuki T, Kakinuma T, Wata‑nabe C, Takae S, Suzuki N, Iwamoto T: Recognition and attitudes of Japanese hema‑tologists on sperm banking before chemo‑therapy: present status from nationwide questionnaire survey. Int. J Clin. Oncol, 2019; 24: 94-102. 19) Mulhall JP, Matsushita K, Nelson CJ: Testos‑terone Levels Are Not Associated With Magnitude of Deformity in Men With Peyronie’s Disease. J Sex Med, 2019, 16: 1283-1289. 20) Uemura H, Uemura H, Nagamori S, Waku‑moto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawa‑saki Y, Yonese J, Nasu Y, Fukasawa S, Sugi‑yama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N: Three-year follow- up of a phase II study of radium-223 dichlo‑ride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases. Int J Clin Oncol, 2019; 24: 557-566. 21) Tasaki M, Saito K, Nakagawa Y, Imai N, Ito Y, Yoshida Y, Ikeda M, Ishikawa S, Narita I, Takahashi K, Tomita Y: Analysis of the prev‑alence of systemic de novo thrombotic micro‑angiopathy after ABO-incompatible kidney transplantation and the associated risk factors. Int J Urol, 2019; 26: 1128-1137. 22) Yoshida T, Takamura M, Goto R, Takeuchi S, Tsuchiya A, Kamimura K, Tasaki M, Nakagawa Y, Saito K, Tomita Y, Terai S: Efficacy and safety of ribavirin therapy for chronic hepa‑titis E after kidney transplantation. Hepatol Res, 2019; 49: 1244-1248. 23) Tasaki M, Saito K, Nakagawa Y, Ikeda M, Imai N, Ito Y, Sudo M, Ikezumi Y, Yamada T, Hasegawa H, Kobayashi T, Miura K, Narita I, Takahashi K, Tomita Y: Bortezomib Elimi‑69

元のページ  ../index.html#71

このブックを見る